Kinetic Modeling and Efficacy of Intraperitoneal Paclitaxel Combined with Intravenous Cyclophosphamide and Carboplatin as First-Line Treatment in Ovarian Cancer

By Hofstra L.S.   Bos A.M.E.   de Vries E.G.E.   van der Zee A.G.J.   Willemsen A.T.M.   Rosing H.   Beijnen J.H.   Mulder N.H.   Aalders J.G.   Willemse P.H.B.  

Gynecologic Oncology, Vol. 85, Iss. 3, 2002-06 ,pp. : 517-523

Academic Press

Access to resources Recommend Favorite

Complications Relating to Intraperitoneal Administration of Cisplatin or Carboplatin for Ovarian Carcinoma

By Sakuragi N.   Nakajima A.   Nomura E.   Noro N.   Yamada H.   Yamamoto R.   Fujimoto S.  

Gynecologic Oncology, Vol. 79, Iss. 3, 2000-12 ,pp. : 420-423

Elsevier

Access to resources Recommend Favorite

Hypersensitivity Reactions to Carboplatin - To the Editor

By Markman M.  

Gynecologic Oncology, Vol. 84, Iss. 2, 2002-02 ,pp. : 353-354

Elsevier

Access to resources Recommend Favorite

First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up

By Fujiwara K.   Sakuragi N.   Suzuki S.   Yoshida N.   Maehata K.   Nishiya M.   Koshida T.   Sawai H.   Aotani E.   Kohno I.  

Gynecologic Oncology, Vol. 90, Iss. 3, 2003-09 ,pp. : 637-643

Elsevier

Access to resources Recommend Favorite

A case of prolonged carboplatin therapy in a patient with carboplatin hypersensitivity

By McElroy T.M.   Gruenigen V.E.v.   Waggoner S.E.  

Gynecologic Oncology, Vol. 91, Iss. 2, 2003-11 ,pp. : 435-437

Elsevier

Access to resources Recommend Favorite